-->

Tiger Brands not opposing listeriosis litigation being certified as class action

Organisation: Position: Deadline Date: Location:

Lawyers representing victims of the listeriosis outbreak will approach the South Gauteng High Court to certify the litigation as a class action. Tiger Brands, the respondent, is not opposing it.

Thamsanqa Malusi, of Richard Spoor Attorneys, is quoted in The Times as saying: “We will argue why the case is best suited for a class action.” He said the firm would be representing everyone who had been affected by listeriosis. “There are 1,060 confirmed cases and we got formal instructions from 150 people. This, however, does not mean that we will exclude those who did not come forward.”

Malusi said once the court certifies the case as a class action, the liability issue would be dealt with. “We will then have to figure out the extent of the damage and get any information that will help us quantify the damage.” Included in the process will be medical assessments of victims of listeriosis, Malusi said.

Attorney Richard Spoor said in the report the positive aspect about the case was the fact that Tiger Brands, who is the respondent, is not opposing it being classified as a class action. Spoor said: “It’s interesting and unique. This is quite a good and positive sign. What’s more important is that class actions can be good for victims and respondents. It can be for the benefit of both Tiger Brands and the victims,” Spoor said.

He said despite the company and lawyers agreeing on the classification of the case, a judge would still need to make an order to that effect. “The judge can confirm that the matter is a class action.”

On 3 September‚ Health Minister Aaron Motsoaledi declared the listeriosis outbreak over‚ leaving the final outbreak tally at 1‚065 confirmed cases – 87 of them emerging after the recall on March 5 – and 218 recorded deaths.

Motsoaledi had identified Tiger Brands’ Enterprise processed-meat plant in the northeast of the country as the source of listeriosis outbreak, the report said.

The Times report

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.